Greenwich, CTCIK 18560834 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
53 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Immunovant Inc | 11.53M | $293.02M | 6.7% | +1.80M | Added |
| 2 | Guardant Health Inc | 2.80M | $285.99M | 6.5% | −1.35M | Reduced |
| 3 | Structure Therapeutics Inc | 4.11M | $285.97M | 6.5% | −104.0K | Reduced |
| 4 | Tarsus Pharmaceuticals Inc |
| 3.00M |
| $245.97M |
| 5.6% |
| +4.0K |
| Added |
| 5 | Dynavax Technologies Corp | 15.73M | $241.87M | 5.5% | 0 | Held |
| 6 | Cytokinetics Inc | 3.34M | $212.03M | 4.8% | −963.0K | Reduced |
| 7 | Axsome Therapeutics Inc | 1.15M | $210.04M | 4.8% | +250.0K | Added |
| 8 | Apellis Pharmaceuticals Inc | 7.75M | $194.68M | 4.4% | −250.4K | Reduced |
| 9 | Vaxcyte Inc | 4.00M | $184.56M | 4.2% | +1.00M | Added |
| 10 | Maze Therapeutics Inc | 4.25M | $175.93M | 4.0% | +297.5K | Added |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio